SAM
SNDX icon

Smartleaf Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Smartleaf Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.2K Hold
2,579
– – ﹤0.01% 1458
2026
Q1 		$58K Sell
2,579
-80
-3% -$1.74K ﹤0.01% 1382
2025
Q4 		$55.1K Buy
2,659
+2,564
+2,699% +$44.7K ﹤0.01% 1501
2025
Q3 		$1.48K Buy
95
+44
+86% +$576 ﹤0.01% 2679
2025
Q2 		$461 Sell
51
-581
-92% -$6.39K ﹤0.01% 2602
2025
Q1 		$8.33K Buy
632
+15
+2% +$212 ﹤0.01% 1997
2024
Q4 		$7.72K Buy
617
+122
+25% +$2.09K ﹤0.01% 2090
2024
Q3 		$9.35K Buy
495
+242
+96% +$5K ﹤0.01% 1794
2024
Q2 		$5.14K Buy
253
+228
+912% +$4.77K ﹤0.01% 1792
2024
Q1 		$576 Buy
+25
New +$558 ﹤0.01% 1720

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Smartleaf Asset Management's SNDX Position: Q2 2026 in Review

Smartleaf Asset Management held its Syndax Pharmaceuticals (SNDX) position steady in Q2 2026 at 2,579 shares worth $56.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1458.

Smartleaf Asset Management first reported a position in SNDX in Q1 2024 and has held it in 10 quarters since. The position peaked at $58K in Q1 2026. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Smartleaf Asset Management held 2,579 shares of Syndax Pharmaceuticals worth $56.2K as of Q2 2026.
  • Smartleaf Asset Management left its Syndax Pharmaceuticals share count unchanged in Q2 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #1458 holding.
  • Smartleaf Asset Management first reported a position in Syndax Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Smartleaf Asset Management's Syndax Pharmaceuticals position peaked at $58K in Q1 2026.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.